Dallas Fort Worth Injury Lawyer Blog
Federal Multidistrict LitigationActos Bladder Cancer Set for Federal Trial
Federal Multidistrict LitigationDr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Articles Posted in Personal Injury
Federal Multidistrict LitigationByetta, Januvia Pancreatic Cancer Litigation Update
In the federal court system, a Multidistrict Litigation (MDL) has been established to centralize Byetta, Januvia, Janumet and Victoza pancreatic cancer lawsuits filed in U.S. District Courts by the users of these diabetic drugs.
There are currently at least 262 cases consolidated as part of an MDL, before U.S. District Judge Battaglia in the Southern District of California. Next discovery and pretrial proceedings will proceed, and bellwether trials will be scheduled, probably some time in 2015.
Boston Scientific Vaginal Mesh Lawsuits Moving Ahead
In personal injury and Mass Tort cases, most states have a 2 year Statute of Limitations, which typically begins to run from the date of the injury or when the injured party knew or should have know that the injury was cause by the defective drug or medical device.
This is a method by which the courts and by states legislatures to put a hard time limit on cases so that folks cannot bring cases for injuries that happened years ago, otherwise there would be no end to litigation.
Stryker Settles Some Rejuvenate Metal on Metal Hip Lawsuits
Encouraging news for affected victims of the Stryker Rejuvenate metal on metal hips. An agreement has been reached to settle at least four Stryker Rejuvante hip lawsuits during early mediation process.
Howmedica Osteonics Corp., the parent company, and Stryker faces about 1,000 lawsuits over problems with their Rejuvenate and ABG II hip implants. Stryker the hip manufacturer, recalled the implants in July 2012, after reports revealed that an inordinate number were failing prematurely.
California Byetta, Januvia Pancreatic Cancer Lawsuits
All Byetta, Januvia, Janumet and Victoza cancer lawsuits are consolidated and centralized as part of an MDL, or Multidistrict Litigation.
These product liability cases involve pancreatic cancer after the use of Byetta, Januvia, Janumet or Victoza as part of the “Incretin Mimetics Product Liability Litigation.”
Toyota Settle Sudden Acceleration Car Accident and Wrongful Death Cases
According to the New York Times, Toyota has decided to enter into a global settlement over sudden acceleration death and injury cases. The announcement comes two months after a Toyota Camry’s electronic throttle system was found to be defective by an Oklahoma jury.
The jury found that Toyota had acted with “reckless disregard,” despite reports of problems in the cars, and was liable for a crash in 2005 that killed one woman and injured another.Toyota Motor Corporation and lawyers pursuing claims alleging the company’s vehicles suddenly accelerated, causing deaths or injuries, will begin an “intensive settlement process” to resolve the lawsuits.
U.S. District Judge James V. Selna in Santa Ana, California, on Friday December 13, issued an order halting the suits after Toyota and the lawyers asked for time to try settling the cases. Selna was scheduled to hear the first trial in March of about 200 federal claims consolidated before him.
DePuy ASR Settlement Criteria and Process Explained
On November 19, in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.475 billion to settle thousands of lawsuits over its recalled hip implants.
Johnson & Johnson Settlement Details
Topamax: Johnson and Johnson, Janssen $11 Million Jury Verdict
Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals unit lost a jury trial in Philadelphia over its drug Topamax. The jury ordered the companies to pay $11 million in a product liability lawsuit which claimed that the anti-seizure drug Topamax caused birth defects.
Jury: Failure to Warn
Jurors in state court in Philadelphia found that Janssen failed to adequately warn doctors for Haley Powell, of the risks of Topamax before she gave birth to a son with a cleft lip.
Smith and Nephew Birmingham Hip and R3 Acetabular Lawsuits
There has been many warnings issued to health departments world wide about potential problems with Smith & Nephew’s Birmingham metal-on-metal hip replacements. These hip model and others including the R3 model, have been linked to a high failure rate according to implant registry data in Europe and Australia.
Smith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.
According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.